Yahoo
Canadian Sec - Free Realtime Quote CAD

Izotropic Corporation (IZO.CN)

0.1700 0.0000 (0.00%)
As of October 5 at 2:19:36 PM EDT. Market Open.
Chart Range Bar
Loading chart for IZO.CN
  • Previous Close 0.1700
  • Open 0.0000
  • Bid 0.1750 x --
  • Ask 0.1950 x --
  • Day's Range 0.1700 - 0.1700
  • 52 Week Range 0.1700 - 0.4900
  • Volume 0
  • Avg. Volume 19,526
  • Market Cap (intraday) 12.168M
  • Beta (5Y Monthly) 2.52
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.

izocorp.com

--

Full Time Employees

April 30

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

IZO.CN
40.35%
S&P/TSX Composite index (^GSPTSE)
12.05%

1-Year Return

IZO.CN
53.42%
S&P/TSX Composite index (^GSPTSE)
16.94%

3-Year Return

IZO.CN
26.09%
S&P/TSX Composite index (^GSPTSE)
85.52%

5-Year Return

IZO.CN
82.29%
S&P/TSX Composite index (^GSPTSE)
76.83%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue --
Earnings --
Profit Margin 0.00%

Q3

FY26

Q4

FY26

Q1

FY27

0
0.0%

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    14.82M

  • Enterprise Value

    17.71M

  • Trailing P/E

    --

  • Forward P/E

    4.99

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -366.51%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.29M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    57.78k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -424.17k

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: